Selected research
Industry Research
Pulmonary Arterial Hypertension Equipment Industry Research Report 2026
Market perspective
The global Pulmonary Arterial Hypertension Equipment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pulmonary Arterial Hypertension Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pulmonary Arterial Hypertension Equipment is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pulmonary Arterial Hypertension Equipment is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pulmonary Arterial Hypertension Equipment include Medtronic, V-Wave Ltd, Swan-Ganz, SoniVie, Smiths Medical, Pulnovo Medical (Wuxi) Co.,Ltd., Philips, Nonin Medical and Masimo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pulmonary Arterial Hypertension Equipment market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pulmonary Arterial Hypertension Equipment Market by Company
Medtronic
V-Wave Ltd
Swan-Ganz
SoniVie
Smiths Medical
Pulnovo Medical (Wuxi) Co.,Ltd.
Philips
Nonin Medical
Masimo
GE Healthcare
Aria CV
Pulmonary Arterial Hypertension Equipment Segment by Type
Diagnostic Equipment
Treatment Equipment
Pulmonary Arterial Hypertension Equipment Segment by Application
Home Care
Hospital
Clinic
Pulmonary Arterial Hypertension Equipment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmonary Arterial Hypertension Equipment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pulmonary Arterial Hypertension Equipment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmonary Arterial Hypertension Equipment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pulmonary Arterial Hypertension Equipment manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pulmonary Arterial Hypertension Equipment by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pulmonary Arterial Hypertension Equipment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Diagnostic Equipment
- Treatment Equipment
Applications
- Home Care
- Hospital
- Clinic
Companies covered
- Medtronic
- V-Wave Ltd
- Swan-Ganz
- SoniVie
- Smiths Medical
- Pulnovo Medical (Wuxi) Co.,Ltd.
- Philips
- Nonin Medical
- Masimo
- GE Healthcare
- Aria CV
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pulmonary Arterial Hypertension Equipment Market Size (2021-2032)
- 2.2.2 Global Pulmonary Arterial Hypertension Equipment Sales (2021-2032)
- 2.2.3 Global Pulmonary Arterial Hypertension Equipment Market Average Price (2021-2032)
- 2.3 Pulmonary Arterial Hypertension Equipment by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Diagnostic Equipment
- 2.3.3 Treatment Equipment
- 2.4 Pulmonary Arterial Hypertension Equipment by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Home Care
- 2.4.3 Hospital
- 2.4.4 Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pulmonary Arterial Hypertension Equipment Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pulmonary Arterial Hypertension Equipment Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Pulmonary Arterial Hypertension Equipment Revenue of Manufacturers (2021-2026)
- 3.4 Global Pulmonary Arterial Hypertension Equipment Average Price by Manufacturers (2021-2026)
- 3.5 Global Pulmonary Arterial Hypertension Equipment Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pulmonary Arterial Hypertension Equipment, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pulmonary Arterial Hypertension Equipment, Product Type & Application
- 3.8 Global Manufacturers of Pulmonary Arterial Hypertension Equipment, Established Date
- 3.9 Global Pulmonary Arterial Hypertension Equipment Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Medtronic
- 4.1.1 Medtronic Company Information
- 4.1.2 Medtronic Business Overview
- 4.1.3 Medtronic Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Medtronic Pulmonary Arterial Hypertension Equipment Product Portfolio
- 4.1.5 Medtronic Recent Developments
- 4.2 V-Wave Ltd
- 4.2.1 V-Wave Ltd Company Information
- 4.2.2 V-Wave Ltd Business Overview
- 4.2.3 V-Wave Ltd Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 V-Wave Ltd Pulmonary Arterial Hypertension Equipment Product Portfolio
- 4.2.5 V-Wave Ltd Recent Developments
- 4.3 Swan-Ganz
- 4.3.1 Swan-Ganz Company Information
- 4.3.2 Swan-Ganz Business Overview
- 4.3.3 Swan-Ganz Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Swan-Ganz Pulmonary Arterial Hypertension Equipment Product Portfolio
- 4.3.5 Swan-Ganz Recent Developments
- 4.4 SoniVie
- 4.4.1 SoniVie Company Information
- 4.4.2 SoniVie Business Overview
- 4.4.3 SoniVie Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 SoniVie Pulmonary Arterial Hypertension Equipment Product Portfolio
- 4.4.5 SoniVie Recent Developments
- 4.5 Smiths Medical
- 4.5.1 Smiths Medical Company Information
- 4.5.2 Smiths Medical Business Overview
- 4.5.3 Smiths Medical Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Smiths Medical Pulmonary Arterial Hypertension Equipment Product Portfolio
- 4.5.5 Smiths Medical Recent Developments
- 4.6 Pulnovo Medical (Wuxi) Co.,Ltd.
- 4.6.1 Pulnovo Medical (Wuxi) Co.,Ltd. Company Information
- 4.6.2 Pulnovo Medical (Wuxi) Co.,Ltd. Business Overview
- 4.6.3 Pulnovo Medical (Wuxi) Co.,Ltd. Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pulnovo Medical (Wuxi) Co.,Ltd. Pulmonary Arterial Hypertension Equipment Product Portfolio
- 4.6.5 Pulnovo Medical (Wuxi) Co.,Ltd. Recent Developments
- 4.7 Philips
- 4.7.1 Philips Company Information
- 4.7.2 Philips Business Overview
- 4.7.3 Philips Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Philips Pulmonary Arterial Hypertension Equipment Product Portfolio
- 4.7.5 Philips Recent Developments
- 4.8 Nonin Medical
- 4.8.1 Nonin Medical Company Information
- 4.8.2 Nonin Medical Business Overview
- 4.8.3 Nonin Medical Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Nonin Medical Pulmonary Arterial Hypertension Equipment Product Portfolio
- 4.8.5 Nonin Medical Recent Developments
- 4.9 Masimo
- 4.9.1 Masimo Company Information
- 4.9.2 Masimo Business Overview
- 4.9.3 Masimo Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Masimo Pulmonary Arterial Hypertension Equipment Product Portfolio
- 4.9.5 Masimo Recent Developments
- 4.10 GE Healthcare
- 4.10.1 GE Healthcare Company Information
- 4.10.2 GE Healthcare Business Overview
- 4.10.3 GE Healthcare Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 GE Healthcare Pulmonary Arterial Hypertension Equipment Product Portfolio
- 4.10.5 GE Healthcare Recent Developments
- 4.11 Aria CV
- 4.11.1 Aria CV Company Information
- 4.11.2 Aria CV Business Overview
- 4.11.3 Aria CV Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Aria CV Pulmonary Arterial Hypertension Equipment Product Portfolio
- 4.11.5 Aria CV Recent Developments
5 Global Pulmonary Arterial Hypertension Equipment Market Scenario by Region
- 5.1 Global Pulmonary Arterial Hypertension Equipment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pulmonary Arterial Hypertension Equipment Sales by Region: 2021-2032
- 5.2.1 Global Pulmonary Arterial Hypertension Equipment Sales by Region: 2021-2026
- 5.2.2 Global Pulmonary Arterial Hypertension Equipment Sales by Region: 2027-2032
- 5.3 Global Pulmonary Arterial Hypertension Equipment Revenue by Region: 2021-2032
- 5.3.1 Global Pulmonary Arterial Hypertension Equipment Revenue by Region: 2021-2026
- 5.3.2 Global Pulmonary Arterial Hypertension Equipment Revenue by Region: 2027-2032
- 5.4 North America Pulmonary Arterial Hypertension Equipment Market Facts & Figures by Country
- 5.4.1 North America Pulmonary Arterial Hypertension Equipment Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2032)
- 5.4.3 North America Pulmonary Arterial Hypertension Equipment Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Pulmonary Arterial Hypertension Equipment Market Facts & Figures by Country
- 5.5.1 Europe Pulmonary Arterial Hypertension Equipment Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2032)
- 5.5.3 Europe Pulmonary Arterial Hypertension Equipment Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Pulmonary Arterial Hypertension Equipment Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pulmonary Arterial Hypertension Equipment Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pulmonary Arterial Hypertension Equipment Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pulmonary Arterial Hypertension Equipment Market Facts & Figures by Country
- 5.7.1 South America Pulmonary Arterial Hypertension Equipment Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2032)
- 5.7.3 South America Pulmonary Arterial Hypertension Equipment Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Pulmonary Arterial Hypertension Equipment Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pulmonary Arterial Hypertension Equipment Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pulmonary Arterial Hypertension Equipment Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2032)
- 6.1.1 Global Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Type (2021-2032)
- 6.2 Global Pulmonary Arterial Hypertension Equipment Revenue by Type (2021-2032)
- 6.2.1 Global Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Type (2021-2032)
- 6.3 Global Pulmonary Arterial Hypertension Equipment Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2032)
- 7.1.1 Global Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Application (2021-2032)
- 7.2 Global Pulmonary Arterial Hypertension Equipment Revenue by Application (2021-2032)
- 7.2.1 Global Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Application (2021-2032)
- 7.3 Global Pulmonary Arterial Hypertension Equipment Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pulmonary Arterial Hypertension Equipment Value Chain Analysis
- 8.1.1 Pulmonary Arterial Hypertension Equipment Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pulmonary Arterial Hypertension Equipment Production Mode & Process
- 8.2 Pulmonary Arterial Hypertension Equipment Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pulmonary Arterial Hypertension Equipment Distributors
- 8.2.3 Pulmonary Arterial Hypertension Equipment Customers
9 Global Pulmonary Arterial Hypertension Equipment Analyzing Market Dynamics
- 9.1 Pulmonary Arterial Hypertension Equipment Industry Trends
- 9.2 Pulmonary Arterial Hypertension Equipment Industry Drivers
- 9.3 Pulmonary Arterial Hypertension Equipment Industry Opportunities and Challenges
- 9.4 Pulmonary Arterial Hypertension Equipment Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst